Tag: Alnylam

Alnylam reports positive results from HELIOS-A phase III study of Vutrisiran...

Alnylam Pharmaceuticals has announced that the HELIOS-A phase III study of Vutrisiran, an investigational RNA interference (RNAi) therapeutic in development for the treatment of...